RF
GILD icon

RHS Financial’s Gilead Sciences GILD Stock Holding History

RHS Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452K Sell
3,574
-892
-20% -$118K 0.18% 90
2026
Q1 		$622K Sell
4,466
-16
-0.4% -$2.24K 0.29% 66
2025
Q4 		$550K Buy
4,482
+205
+5% +$24.9K 0.27% 66
2025
Q3 		$475K Buy
4,277
+2,169
+103% +$247K 0.25% 69
2025
Q2 		$234K Buy
+2,108
New +$224K 0.13% 116

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHS Financial's GILD Position: Q2 2026 in Review

RHS Financial reduced its Gilead Sciences (GILD) stake by 20% in Q2 2026, selling an estimated $118K and leaving 3,574 shares worth $452K. The position accounts for 0.18% of the portfolio, ranked #90.

RHS Financial first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $622K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • RHS Financial held 3,574 shares of Gilead Sciences worth $452K as of Q2 2026.
  • RHS Financial sold 892 Gilead Sciences shares in Q2 2026, an estimated $118K.
  • Gilead Sciences made up 0.18% of RHS Financial's portfolio in Q2 2026, its #90 holding.
  • RHS Financial first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • RHS Financial's Gilead Sciences position peaked at $622K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RHS Financial's 13F filing for Q2 2026, filed 7 Aug 2026.